AngioDynamics Sees Adjusted EPS Loss Of $(0.35)-$(0.42) Versus Prior Guidance Of $(0.28)-$(0.34) And Consensus Of $(0.32)
Portfolio Pulse from Benzinga Newsdesk
AngioDynamics updated its guidance, projecting a larger adjusted EPS loss of $(0.35)-$(0.42) compared to the previous forecast of $(0.28)-$(0.34) and the consensus estimate of $(0.32).
January 05, 2024 | 12:10 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
AngioDynamics has revised its earnings guidance, indicating a larger than expected loss per share, which could negatively impact investor sentiment and the stock price in the short term.
The revised guidance from AngioDynamics suggests a greater loss per share than previously estimated and what analysts had expected. This negative earnings revision typically leads to a decrease in investor confidence and can result in a downward pressure on the stock price in the short term.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100